Literature DB >> 19874468

The prevalence of symptomatic von Willebrand disease in primary care practice.

M Bowman, W M Hopman, D Rapson, D Lillicrap, P James.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19874468     DOI： 10.1111/j.1538-7836.2009.03661.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  52 in total

1.  An international survey to inform priorities for new guidelines on von Willebrand disease.

Authors:  Mohamad A Kalot; Mohammed Al-Khatib; Nathan T Connell; Veronica Flood; Romina Brignardello-Petersen; Paula James; Reem A Mustafa
Journal:  Haemophilia       Date:  2019-11-26       Impact factor: 4.287

2.  Effectiveness and safety of hFVIII/VWF concentrate (Voncento®) in patients with inherited von Willebrand disease requiring surgical procedures: the OPALE multicentre observational study.

Authors:  Lucia Rugeri; Roseline d'Oiron; Annie Harroche; Valérie Proulle; Guillaume Mourey; Emmanuelle De Raucourt; Dominique Desprez; Nathalie Itzhar Baikian; Brigitte Pan Petesch; Annie Borel-Derlon; Sophie Combe; Birgit Frotscher; Abel Hassoun; Hasan Catovic; Diane Bracquart; Marc Trossaërt
Journal:  Blood Transfus       Date:  2020-11-27       Impact factor: 3.443

3.  Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.

Authors:  Veronica H Flood; Pamela A Christopherson; Joan Cox Gill; Kenneth D Friedman; Sandra L Haberichter; Daniel B Bellissimo; Rupa A Udani; Mahua Dasgupta; Raymond G Hoffmann; Margaret V Ragni; Amy D Shapiro; Jeanne M Lusher; Steven R Lentz; Thomas C Abshire; Cindy Leissinger; W Keith Hoots; Marilyn J Manco-Johnson; Ralph A Gruppo; Lisa N Boggio; Kate T Montgomery; Anne C Goodeve; Paula D James; David Lillicrap; Ian R Peake; Robert R Montgomery
Journal:  Blood       Date:  2016-02-09       Impact factor: 22.113

Review 4.  Advances in the diagnosis and treatment of Von Willebrand disease.

Authors:  Ruchika Sharma; Veronica H Flood
Journal:  Blood       Date:  2017-11-30       Impact factor: 22.113

5.  The role of genetics in the pathogenesis and diagnosis of type 1 Von Willebrand disease.

Authors:  Veronica H Flood; Jessica Garcia; Sandra L Haberichter
Journal:  Curr Opin Hematol       Date:  2019-09       Impact factor: 3.284

6.  von Willebrand disease: proposing definitions for future research.

Authors:  Nathan T Connell; Paula D James; Romina Brignardello-Petersen; Rezan Abdul-Kadir; Barbara Ameer; Alice Arapshian; Susie Couper; Jorge Di Paola; Jeroen Eikenboom; Nicolas Giraud; Jean M Grow; Sandra Haberichter; Vicki Jacobs-Pratt; Barbara A Konkle; Peter Kouides; Michael Laffan; Michelle Lavin; Frank W G Leebeek; Claire McLintock; Simon McRae; Robert Montgomery; Sarah H O'Brien; James S O'Donnell; Margareth C Ozelo; Nikole Scappe; Robert Sidonio; Alberto Tosetto; Angela C Weyand; Mohamad A Kalot; Nedaa Husainat; Reem A Mustafa; Veronica H Flood
Journal:  Blood Adv       Date:  2021-01-26

Review 7.  Angiodysplasia in von Willebrand Disease: Understanding the Clinical and Basic Science.

Authors:  Soundarya Selvam; Paula James
Journal:  Semin Thromb Hemost       Date:  2017-05-05       Impact factor: 4.180

8.  Heavy menstrual bleeding and health-associated quality of life in women with von Willebrand's disease.

Authors:  Igor Govorov; Lena Ekelund; Roza Chaireti; Petra Elfvinge; Margareta Holmström; Katarina Bremme; Miriam Mints
Journal:  Exp Ther Med       Date:  2016-03-10       Impact factor: 2.447

9.  Quantification of perioperative changes in von Willebrand factor and factor VIII during elective orthopaedic surgery in normal individuals.

Authors:  A Kahlon; J Grabell; A Tuttle; D Engen; W Hopman; D Lillicrap; P James
Journal:  Haemophilia       Date:  2013-05-28       Impact factor: 4.287

10.  The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles.

Authors:  M Bowman; A Tuttle; C Notley; C Brown; S Tinlin; M Deforest; J Leggo; V S Blanchette; D Lillicrap; P James
Journal:  J Thromb Haemost       Date:  2013-03       Impact factor: 5.824
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.